「標靶藥物」、「生物製劑」和「免疫治療」等新興療法為目前藥理界的新主流，不僅在全身許多疾病上蓬勃地發展，也影響了眼科病患的治療思維。本篇文章對這類藥物的藥理特色做簡要的說明，並簡介這些藥物在眼科疾病的應用，或是可能因為其他科別的應用上，導致病患產生眼科疾病。

“Target therapy”, “biologics” and “immunotherapy” are currently the new mainstreams in the field of clinical pharmacology. They are wildly used in the treatment of ocular diseases. However, systemic use of these drugs may also lead to ocular complications. In this article, the basic concept of these drugs and their role in ophthalmic filed was discussed.